Israeli-based startup ONYX Radiance has launched its AntiViral Defense Mask, which is reported to 'destroy COVID-19 and influenza viruses with 99.99% efficiency.'
Furthermore, the mask is said to filter out > 99.5% of 3-micron particles, providing a barrier against airborne droplets for up to 50 home launderings. These anti-viral results have been verified by a qualified independent laboratory in accordance with the ISO18184 test protocol.
In addition, the company reports the mask has been shown to effectively combat microorganisms that accumulate in textiles, including Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Corynebacterium ammoniagenes and the toxic molds Aspergillus niger and Trichophyton mentagrophytes.
The AntiViral Defense Mask is made of 100% cotton and is infused with a silver ion formula including ONYX's delivery system, designed to ensure continuous release for long-term biocidal efficacy. Silver ions also have shown clinical efficacy to promote smoother, softer, more even-toned and youthful-looking skin with repeated use, the company reports. Users also have stated it can alleviate severe acne conditions and improve sleep quality.
The company notes it plans to execute clinical trials in 2022. This launch follows previous launches including a skin-rejuvenating pillowcase and an acne-combating pillowcase.